Kids who are stars in sports and music don’t usually grow up to be stars as adults, a new study found. An examination of thousands of adults across fields including sports, music, academia and chess ...

AT&T customers are eligible to receive compensation from the telecommunications giant as part of a $177 million settlement over two data breaches last year. AT&T notified millions of customers that ...

You have just a few days to file your claim as part of AT&T's $177 million settlement. The settlement follows two instances where its customers' information was hacked and stolen. In 2019, AT&T was ...

AT&T customers: the deadline for eligible claimants to file for a portion of the $177 million class action settlement is coming up soon. The telecommunications company agreed to the settlement to ...

AT&T agreed to a $177 million settlement for two data incidents in 2024 that exposed customer info. A federal judge is scheduled to grant final approval of the settlement on Jan. 15, 2026. Time is ...

Marc Santos is a Guides Staff Writer from the Philippines with a BA in Communication Arts and over six years of experience in writing gaming news and guides. He plays just about everything, from ...

The deadline to file a claim in the $177 million AT&T class action settlement is fast approaching. Here's what to know about the settlement and how to file a claim. The settlement resolves a lawsuit ...

The deadline to file a claim for money from the $177 million AT&T class action settlement is coming up. AT&T agreed to the settlement to resolve a lawsuit that accused it of failing to protect ...

AT&T will pay a $177 million settlement for a class action lawsuit over multiple customer data breaches. Two classes of customers whose data was compromised in March and July 2024 are eligible for ...

Microsoft is working to resolve a known issue that prevents some users from opening Excel email attachments in the new Outlook client. According to a service alert (EX1189359) seen by BleepingComputer ...

Engineered immune cells are being used to successfully treat people with a range of debilitating autoimmune conditions, such as ulcerative colitis, rheumatoid arthritis and lupus. Researchers say ...